Servier Pharmaceuticals LLC
At a glance
Employees100-499
In business sinceNot reported
HeadquartersBoston, MA
US patents19
SAM.gov UEIG3YUU3BJQNL4
CAGE code8HTU0
Incorporated inDE
Supplier designations
For Profit Organization
Self-certified by the company in its SAM.gov registration
Patents
19 US patents granted 2022–2025, 19 of them in the five years to SEP 2025.
Pharmaceuticals 16Organic fine chemistry 2
- Therapeutically active compounds and their methods of useUS 12,303,512 · granted MAY 20, 2025
- Crystalline and salt forms of an organic compound and pharmaceutical compositions thereofUS 12,297,179 · granted MAY 13, 2025
- Methods of use for trisubstituted benzotriazole derivativesUS 12,290,508 · granted MAY 6, 2025
- Ivosidenib forms and pharmaceutical compositionsUS 12,264,148 · granted APR 1, 2025
- Methods of treating brain tumors using combination therapyUS 12,064,436 · granted AUG 20, 2024
Newest 5 shown · Granted to Servier Pharmaceuticals LLC · PatentsView (USPTO), data through SEP 30, 2025 · CC BY 4.0
Their plant
| Facility | City | State | Employees | Status |
|---|---|---|---|---|
| Servier Pharmaceuticals LLC | Boston | MA | 100–499 | LIKELY ACTIVE |
Compiled from federal records — EPA, OSHA, SAM.gov and the U.S. Census — and from the company’s own website. Federal source data is public domain. Each plant’s page names the source of every field.